ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

N,N'-Dimethylethylenediamine → 4-(4-Methyl-3'-nitro-3,4,5,6-tetrahydro-2h-[1,2']bipyridinyl-6'-yl)-3-oxo-piperazine-1-carboxylic acid benzyl ester

HRID 646930
ノート
印刷プレビュー

反応式

HRID 646930 の反応式
Br[C:2]1[N:7]=[C:6]([N:8]2[CH2:13][CH2:12][CH:11]([CH3:14])[CH2:10][CH2:9]2)[C:5]([N+:15]([O-:17])=[O:16])=[CH:4][CH:3]=1.[CH2:18]([O:25][C:26]([N:28]1[CH2:33][CH2:32][NH:31][C:30](=[O:34])[CH2:29]1)=[O:27])[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1.[O-]P([O-])([O-])=O.[K+].[K+].[K+].CNCCNC>C1(C)C=CC=CC=1.[Cu]I>[CH2:18]([O:25][C:26]([N:28]1[CH2:33][CH2:32][N:31]([C:2]2[N:7]=[C:6]([N:8]3[CH2:13][CH2:12][CH:11]([CH3:14])[CH2:10][CH2:9]3)[C:5]([N+:15]([O-:17])=[O:16])=[CH:4][CH:3]=2)[C:30](=[O:34])[CH2:29]1)=[O:27])[C:19]1[CH:20]=[CH:21][CH:22]=[CH:23][CH:24]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 8070N,N'-DimethylethylenediamineHCID 62657Potassium Phosphate, TribasicHCID 736777Benzyl 3-oxopiperazine-1-carboxylateHCID 586384926'-Bromo-4-methyl-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl

生成物 1

HCID 686819054-(4-Methyl-3'-nitro-3,4,5,6-tetrahydro-2h-[1,2']bipyridinyl-6'-yl)-3-oxo-piperazine-1-carboxylic acid benzyl ester収率 57%

試薬・触媒・溶媒 2

HCID 24350Copper(1+) iodide; Copper(I) iodide; Cuprous iodide; Cuprous iodide (CuI)触媒HCID 1140Toluene溶媒

実験手順

To a solution of 6′-bromo-4-methyl-3′-nitro-3,4,5,6-tetrahydro-2H-[1,2′]bipyridinyl (as prepared in the previous step) (300 mg, 1.00 mmol) in toluene (5 mL) was added 3-oxo-piprazine-1-carboxylic acid benzyl ester (351 mg, 1.50 mmol), K3PO4 (424 mg, 2.00 mmol) and CuI (38 mg, 0.20 mmol) followed by N,N′-dimethylethylenediamine (20 μL, 0.18 mmol) under Ar. The resulting mixture was heated at reflux overnight. The reaction mixture was allowed to cool to room temperature and filtered through a thin pad of Celite. The filtrate was concentrated in vacuo and the residue obtained was purified by chromatography on silica (20% EtOAc:hexane) to obtain 4-(4-methyl-3′-nitro-3,4,5,6-tetrahydro-2H-[1,2′]bipyridinyl-6′-yl)-3-oxo-piperazine-1-carboxylic acid benzyl ester (258 mg, 57%). This compound (453 mg, 1.00 mmol) was dissolved in 30% HBr/HOAc (1 mL). The resulting mixture was stirred at room temperature overnight and Et2O (20 mL) was added dropwise. The resulting mixture was stirred for another hour, the precipitated hydrobromide was collected by suction filtration, washed with Et2O (3×20 mL), dried in vacuo for 1 h and used directly in next step.

後処理

  1. temperatureThe resulting mixture was heated
  2. temperatureat reflux overnight
  3. filtrationfiltered through a thin pad of Celite
  4. concentrationThe filtrate was concentrated in vacuo
  5. customthe residue obtained
  6. customwas purified by chromatography on silica (20% EtOAc:hexane)

出典と根拠

ORDレコード
ord-f83c52a281c946d4b696f008af02118c
出典データセット
uspto-grants-2010_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07705042B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート